Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancer

.

Source: Human Vaccines and Immunotherapeutics - June 11, 2020 Category: Allergy & Immunology Authors: Christopher D. Pack Ramireddy Bommireddy Luis E. Munoz Jaina M. Patel Erica N. Bozeman Paulami Dey Vijayaraghavan Radhakrishnan Vincent F. Vartabedian Kalpana Venkat Sampath Ramachandiran Shaker J. C. Reddy Periasamy Selvaraj Source Type: research